Latest News and Press Releases

Harvard Bioscience Announces First Quarter 2026 Financial Results

Over 315 patients screened and over 230 patients enrolled in BriaCell’s pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint inhibitor in metastatic breast cancer Enrollment momentum...

On track for planned IND submission in mid-2026 and Phase 1 initiation in the second half of 2026 for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2 Presented new preclinical data...

Sylogist Announces First Quarter 2026 Results

Vancouver, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- North American Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (NIOB or the Company) has completed a...

Growth + Income Emerges as a Category: TappAlpha Crosses $500M AUM, Doubling in Four Months

Q1 GAAP revenue of $106.2 million increased 333.5% year-over-year, driven by recently closed M&A transactions Moves to 4th largest cannabis company on a pro forma basis by revenue Closed the...

LONDON, May 12, 2026 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced...

Revenue of $106.9 million, revenue growth of 32% Organic revenue growth of 26% (1) Net income of $1.3 million with Adjusted EBITDA of $13.9 million (1) Company reaffirms full year 2026 guidance ...

BOSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare...